Position in REGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$151,653,006
+$23,125,845 QoQ
Shares Held
196,279
+17.9% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 62.815685834959424.ToString("F0")%
Shared 0.ToString("F0")%
None 37.184314165040576.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LSV ASSET MANAGEMENT holds $1,556,348,509 across 16 Biotechnology names. REGN ranks #4 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
2,386,840 | $451,232,102 | |
| 2 | INCY |
Incyte Corp
|
3,920,056 | $368,955,670 | |
| 3 | EXEL |
Exelixis, Inc.
|
7,745,715 | $332,213,716 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
196,279 | $151,653,006 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
1,371,558 | $88,643,793 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,025,143 | $56,724,255 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
884,800 | $49,982,352 | |
| 8 | RIGL |
Rigel Pharmaceuticals Inc
|
601,507 | $16,264,749 |
All Filings in REGN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $151,653,006 | 196,279 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $128,527,161 | 166,514 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $31,262,212 | 55,600 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $5,073 | 8 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,849 | 4 | Shares | Sole | 2025-02-13 | |
| 2023-03-31 | $40,590,498 | 49,400 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $37,589,629 | 52,100 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $37,061,206 | 53,800 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $33,930,862 | 57,400 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $133,908,066 | 191,730 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $126,466,300 | 200,257 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $127,007,311 | 209,867 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $132,031,594 | 236,387 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $119,208,096 | 251,951 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $127,387,411 | 263,682 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $167,157,025 | 298,612 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $200,588,291 | 321,636 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $188,059,034 | 385,138 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||